Tag: Phase 2 clinical trial

Faeth Therapeutics | The GOG Foundation, Inc.

Faeth Therapeutics and The Gog Foundation, Inc. Unveil Phase 2 Combination Trial of Sapanisertib and Serabelisib for Endometrial Cancer Patients

by Bioengineer

March 13, 2025

FAETH THERAPEUTICS AND THE GOG FOUNDATION, INC. LAUNCH FIRST PHASE 2 COMBINATION TRIAL FOR SAPANISERTIB-SERABELISIB IN PATIENTS WITH ENDOMETRIAL CANCER ...

No Result

View All Result

Homepages
- Home Page 1
- Home Page 2
News
National
Business
Health
Lifestyle
Science

Tag: Phase 2 clinical trial

Faeth Therapeutics and The Gog Foundation, Inc. Unveil Phase 2 Combination Trial of Sapanisertib and Serabelisib for Endometrial Cancer Patients

POPULAR NEWS

Breakthrough Research Reveals Fuel Accumulation in Fusion Vessel Inner Walls

Virginia Tech Study Reveals Machine Learning Models Struggle to Identify Critical Health Declines

Amplified Sciences Achieves CLIA Certification for Groundbreaking Test to Evaluate Pancreatic Cancer Risk

Scientists Develop Self-Healing Gel Inspired by Human Skin

About

Follow us

Recent News

Promising Results for New Hepatitis B Vaccine as a Booster for Healthcare Workers

Family-Oriented Lifestyle Interventions Enhance Weight Control and Cardiovascular Health in High-Risk Patients

Prolonged Use of Inhaled Corticosteroids in COPD Associated with Significant Long-Term Health Risks

Welcome Back!

Retrieve your password